This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Sep;14(9):517.

doi: 10.1038/nrurol.2017.129. Epub 2017 Aug 1.

Incontinence: Patients prefer combination therapy

PMID: 28762389
DOI: 10.1038/nrurol.2017.129

Comment

Incontinence: Patients prefer combination therapy

Peter Sidaway. Nat Rev Urol. 2017 Sep.

. 2017 Sep;14(9):517.

doi: 10.1038/nrurol.2017.129. Epub 2017 Aug 1.

Author

PMID: 28762389
DOI: 10.1038/nrurol.2017.129

No abstract available

PubMed Disclaimer

Comment on

Patient-reported outcomes from SYNERGY, a randomized, double-blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients.
Robinson D, Kelleher C, Staskin D, Mueller ER, Falconer C, Wang J, Ridder A, Stoelzel M, Paireddy A, van Maanen R, Hakimi Z, Herschorn S. Robinson D, et al. Neurourol Urodyn. 2018 Jan;37(1):394-406. doi: 10.1002/nau.23315. Epub 2017 Jul 13. Neurourol Urodyn. 2018. PMID: 28704584 Clinical Trial.

References

1. Neurourol Urodyn. 2017 Jul 13;:null - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations